Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hyperion DeFiHYPD -1.08%43 Return-on-Tangible-Asset is 162.83% as of Mar. 2026. GuruFocus rates HYPD with a GF Score™ of 43/100 and a GF Value™ of $16.53 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,416 Biotechnology companies, Hyperion DeFi ranks worse than 80.58% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Hyperion DeFi's annualizedNet Income for the quarter that ended in Mar. 2026 was $35.36 Mil. Hyperion DeFi's average total tangible assets for the quarter that ended in Mar. 2026 was $21.72 Mil. Therefore, Hyperion DeFi's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 162.83%.
The historical rank and industry rank for Hyperion DeFi's Return-on-Tangible-Asset or its related term are showing as below:
HYPD'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -490.01 Med: -113.05 Max: -38.98
Current: -107.92
During the past 11 years, Hyperion DeFi's highest Return-on-Tangible-Asset was -38.98%. The lowest was -490.01%. And the median was -113.05%.
HYPD's Return-on-Tangible-Asset is ranked worse than 80.58% of 1416
companies
in the Biotechnology industry
Industry Median: -35.915
vs HYPD: -107.92
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Hyperion DeFi Return-on-Tangible-Asset Related Terms
Hyperion DeFi Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Hyperion DeFi's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HYPD vs MGX, KALA, APLM: Return-on-Tangible-Asset Comparison
For the Biotechnology subindustry, Hyperion DeFi's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyperion DeFi Return-on-Tangible-Asset vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hyperion DeFi's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Hyperion DeFi's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 162.83% mean?
Hyperion DeFi (HYPD) has a Return-on-Tangible-Asset of 162.83% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Hyperion DeFi and its competitors. According to the industry distribution chart, Hyperion DeFi ranks #1141 out of 1416 companies in the Biotechnology industry, placing it in the top 80.6%.
Is Hyperion DeFi's Return-on-Tangible-Asset too high?
Hyperion DeFi's current Return-on-Tangible-Asset is 162.83%. Based on the distribution chart, Hyperion DeFi ranks #1141 out of 1416 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hyperion DeFi has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hyperion DeFi's Return-on-Tangible-Asset compare to MGX and KALA?
According to the Biotechnology industry distribution chart, Hyperion DeFi ranks #1141 out of 1416 companies for Return-on-Tangible-Asset. This places Hyperion DeFi in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Hyperion DeFi and its competitors. Hyperion DeFi's current Return-on-Tangible-Asset is 162.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyperion DeFi stock overvalued right now?
Based on GuruFocus' analysis, Hyperion DeFi (HYPD) is currently considered Possible Value Trap. The stock's GF Value™ is $16.53, compared to a current price of $2.74 — trading 83.4% below its estimated fair value. The current Return-on-Tangible-Asset is 162.83%. Hyperion DeFi's overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Hyperion DeFi (HYPD), the current Return-on-Tangible-Asset is 162.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyperion DeFi (HYPD) Overvalued in 2026?
Based on GuruFocus' analysis, Hyperion DeFi stock appears to be undervalued.
The current stock price of $2.74 is trading 83.4% below its estimated GF Value™ of $16.53.
GuruFocus considers Hyperion DeFi to be Possible Value Trap.
Key valuation signals for HYPD:
Return-on-Tangible-Asset: 162.83%
GF Value™: $16.53 vs. price of $2.74 (83.4% below fair value)
No single metric tells the full story. See the HYPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE. The Company is focused on providing its shareholders with simplified access to the Hyperliquid ecosystem, one of the fastest-growing and highest-revenue-generating blockchains in the world. Shareholders benefit from a gradually compounding exposure to HYPE, both from its native staking yield and additional revenues generated from its on-chain utility. It is working to provide its shareholders with simplified exposure to the Hyperliquid ecosystem, which is believed to be among the highest-revenue-generating blockchains in the world, according to information from various blockchain data tracking sources, including Artemis Analytics and DefiLlama.
43GF Score
Get the complete analysis for HYPD
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HYPD has been successfully added to your 
